About Prostate Cancer
Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. The prostate is a gland in the male reproductive system located just below the bladder and in front of the rectum. It is about the size of a walnut and surrounds the urethra (the tube that empties urine from the bladder). The prostate gland produces fluid that is one of the components of semen.
Prostate cancer is the most common (non-skin) cancer in men. Approximately 238,000 new cases of prostate cancer will be diagnosed in the United States during 2013 and about 30,000 will die from the disease. About 1 man in 6 will be diagnosed with prostate cancer during his lifetime.
Prognosis & Treatment
Treatment options and prognosis depend on the stage of the cancer, the Gleason score, and the patient’s age and general health. With greater public awareness, early detection is on the rise and mortality rates are declining. Additionally, new advances in medical technology are enabling cancer patients to return to active and productive lives after their treatment.
- Prostate Cancer Foundation. Prostate Cancer FAQs. Available from: http://www.pcf.org/site/c.leJRIROrEpH/b.5800851/k.645A/Prostate_Cancer_FAQs.htm
Important Safety Information
Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Individual surgical results may vary. Patients should talk to their doctor to decide if da Vinci Surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. Please also refer to http://www.daVinciSurgery.com/Safety for Important Safety Information.
When Is Single-Site Technology Used and What Are the Risks?
da Vinci Surgery with Single-Site® Instruments is cleared for use in gallbladder removal, and for hysterectomy and ovary removal for benign conditions. Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci Surgery, including da Vinci Surgery with Single-Site Instruments. There may be an increased risk of incision-site hernia with single-incision surgery, including Single-Site surgery with the da Vinci System. Single-Site® Instruments for the da Vinci® Si™ System bear the CE mark. This device is cleared for commercial distribution in the U.S. for laparoscopic cholecystectomy, and for hysterectomy and salpingo-oophorectomy for benign conditions.
© 2015 Intuitive Surgical, Inc. All rights reserved. Product names are trademarks or registered trademarks of their respective holders.